105 related articles for article (PubMed ID: 31661787)
1. Cancer Survival Data Representation for Improved Parametric and Dynamic Lifetime Analysis.
Vandamme LKJ; Wouters PAAF; Slooter GD; de Hingh IHJT
Healthcare (Basel); 2019 Oct; 7(4):. PubMed ID: 31661787
[TBL] [Abstract][Full Text] [Related]
2. Applying conventional and saturated generalized gamma distributions in parametric survival analysis of breast cancer.
Yavari P; Abadi A; Amanpour F; Bajdik C
Asian Pac J Cancer Prev; 2012; 13(5):1829-31. PubMed ID: 22901130
[TBL] [Abstract][Full Text] [Related]
3. Bayesian inference in a piecewise Weibull proportional hazards model with unknown change points.
Casellas J
J Anim Breed Genet; 2007 Aug; 124(4):176-84. PubMed ID: 17651319
[TBL] [Abstract][Full Text] [Related]
4. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].
Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G
Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442
[TBL] [Abstract][Full Text] [Related]
5. An alternative competing risk model to the Weibull distribution for modelling aging in lifetime data analysis.
Bousquet N; Bertholon H; Celeux G
Lifetime Data Anal; 2006 Dec; 12(4):481-504. PubMed ID: 17021959
[TBL] [Abstract][Full Text] [Related]
6. Exponentiated Weibull regression for time-to-event data.
Khan SA
Lifetime Data Anal; 2018 Apr; 24(2):328-354. PubMed ID: 28349290
[TBL] [Abstract][Full Text] [Related]
7. Comparison of nasal intermittent positive pressure ventilation and nasal continuous positive airway pressure treatments using parametric survival models.
Baneshi MR; Bahmanbijari B; Mahdian R; Haji-Maghsoodi S; Nikbakht R
Iran J Pediatr; 2014 Apr; 24(2):207-13. PubMed ID: 25535541
[TBL] [Abstract][Full Text] [Related]
8. A Comparison of Different Analysis Methods for Reconstructed Survival Data to Inform Cost‑Effectiveness Analysis.
Djalalov S; Beca J; Ewara EM; Hoch JS
Pharmacoeconomics; 2019 Dec; 37(12):1525-1536. PubMed ID: 31571137
[TBL] [Abstract][Full Text] [Related]
9. [The prognostic factors in astrocytic tumors: analysis by the Kaplan-Meier method and the Weibull log-linear model].
Hirano H; Asakura T; Yokoyama S; Kadota K; Kasamo S; Okahara K; Hirakawa W; Niiro M; Nakamura K; Nakayama M; Yamasaki I
No Shinkei Geka; 1996 Sep; 24(9):809-15. PubMed ID: 8827730
[TBL] [Abstract][Full Text] [Related]
10. Weibull-like Model of Cancer Development in Aging.
Mdzinarishvili T; Sherman S
Cancer Inform; 2010 Aug; 9():179-88. PubMed ID: 20838610
[TBL] [Abstract][Full Text] [Related]
11. Estimating the loss of lifetime function using flexible parametric relative survival models.
Jakobsen LH; Andersson TM; Biccler JL; El-Galaly TC; Bøgsted M
BMC Med Res Methodol; 2019 Jan; 19(1):23. PubMed ID: 30691400
[TBL] [Abstract][Full Text] [Related]
12. Estimating Lifetime Benefits Associated with Immuno-Oncology Therapies: Challenges and Approaches for Overall Survival Extrapolations.
Ouwens MJNM; Mukhopadhyay P; Zhang Y; Huang M; Latimer N; Briggs A
Pharmacoeconomics; 2019 Sep; 37(9):1129-1138. PubMed ID: 31102143
[TBL] [Abstract][Full Text] [Related]
13. Estimating the survival functions for right-censored and interval-censored data with piecewise constant hazard functions.
He P; Kong G; Su Z
Contemp Clin Trials; 2013 Jul; 35(2):122-7. PubMed ID: 23664967
[TBL] [Abstract][Full Text] [Related]
14. Parametric survival analysis and taxonomy of hazard functions for the generalized gamma distribution.
Cox C; Chu H; Schneider MF; Muñoz A
Stat Med; 2007 Oct; 26(23):4352-74. PubMed ID: 17342754
[TBL] [Abstract][Full Text] [Related]
15. Comparison of different parametric proportional hazards models for interval-censored data: a simulation study.
Gong Q; Fang L
Contemp Clin Trials; 2013 Sep; 36(1):276-83. PubMed ID: 23916917
[TBL] [Abstract][Full Text] [Related]
16. Survival Analysis of Patients with Breast Cancer using Weibull Parametric Model.
Baghestani AR; Moghaddam SS; Majd HA; Akbari ME; Nafissi N; Gohari K
Asian Pac J Cancer Prev; 2015; 16(18):8567-71. PubMed ID: 26745118
[TBL] [Abstract][Full Text] [Related]
17. Dynamic Contrast-Enhanced MRI-Derived Intracellular Water Lifetime (τ
Chawla S; Loevner LA; Kim SG; Hwang WT; Wang S; Verma G; Mohan S; LiVolsi V; Quon H; Poptani H
AJNR Am J Neuroradiol; 2018 Jan; 39(1):138-144. PubMed ID: 29146716
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
19. A flexible parametric survival model for fitting time to event data in clinical trials.
Liao JJZ; Liu GF
Pharm Stat; 2019 Oct; 18(5):555-567. PubMed ID: 31037824
[TBL] [Abstract][Full Text] [Related]
20. The exponentiated exponential mixture and non-mixture cure rate model in the presence of covariates.
Mazucheli J; Coelho-Barros EA; Achcar JA
Comput Methods Programs Biomed; 2013 Oct; 112(1):114-24. PubMed ID: 23932336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
